drugset / Trial / NCT05155657
Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells
Non-randomizedSequentialSingle-blindTreatment
Summary
The main purpose of this study is to evaluate the safety and tolerance of umbilical cord mesenchymal stem cells (UCMSCs) in patients with decompensated alcoholic cirrhosis, and to provide dose basis for subsequent clinical study design. We will also explore the possible mechanism of UCMSCs in the treatment of decompensated alcoholic cirrhosis (DAC).
Timeline
- Start
- 2022-06-13
- Primary completion
- 2024-12-25
- Completion
- 2024-12-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mesenchymal stem cells | Cell therapy | 500000 cells/kg | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Subject | mesenchymal stem cells | Cell therapy | 2e+06 cells/kg | Intravenous |